Welcure Drugs & Pharmaceuticals Share Price
₹12.92 -0.68 (-5%)
29 Dec, 2024 09:03
Start SIP in WELCURE
Start SIPPerformance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume0
Investment Returns
- Over 1 Month + 60.1%
- Over 3 Month + 68.01%
- Over 6 Month + 159.44%
- Over 1 Year + 225.44%
Smart Investing Starts Here Start SIP with Welcure Drugs & Pharmaceuticals for Steady Growth!
Welcure Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Welcure Drugs & Pharmaceuticals Financials
Welcure Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹12.92
-0.68
(-5%)
- Bullish Moving Average 13
- Bearish Moving Average 3
- 20 Day
- ₹11.48
- 50 Day
- ₹9.10
- 100 Day
- ₹7.43
- 200 Day
- ₹6.18
Resistance and Support
13.15
- R3 14.05
- R2 13.83
- R1 13.37
- S1 12.69
- S2 12.47
- S3 12.01
Welcure Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-14 | Quarterly Results | (Revised) |
2024-10-21 | Others | |
2024-08-14 | Quarterly Results | |
2024-06-10 | Others | Inter alia, 1. To augment of financial resources of the company, 2. To increase in authorised share capital of the company and 3. To shift branch office of the company. |
2024-05-30 | Audited Results | (Revised) |
Welcure Drugs & Pharmaceuticals F&O
About Welcure Drugs & Pharmaceuticals
- NSE Symbol
- WELCURE
- BSE Symbol
- 524661
- Managing Director & CFO
- Mr. Altaf Hussain Shah
- ISIN
- INE331C01017
Similar Stocks to Welcure Drugs & Pharmaceuticals
Welcure Drugs & Pharmaceuticals FAQs
Welcure Drugs & Pharmaceuticals share price is ₹12 As on 29 December, 2024 | 08:49
The Market Cap of Welcure Drugs & Pharmaceuticals is ₹17.5 Cr As on 29 December, 2024 | 08:49
The P/E ratio of Welcure Drugs & Pharmaceuticals is 12.1 As on 29 December, 2024 | 08:49
The PB ratio of Welcure Drugs & Pharmaceuticals is 13 As on 29 December, 2024 | 08:49
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.